weight-loss-drugs
6 stories related to this topic, newest first.
news18.comFrench Regulator Fines Novo Nordisk and Eli Lilly for Weight Loss Drug Advertising Violations
France's medicines regulator imposed fines on Novo Nordisk and Eli Lilly for misleading advertisements related to their weight loss drugs. The penalties come amid launches of oral GLP-1 medications in the U.S., with Novo Nordisk's Wegovy pill gaining early traction. Company execu…
CMS Launches Medicaid Fraud Crackdown as Insurers Opt Out of Medicare Weight Loss Drug Pilot
The Centers for Medicare & Medicaid Services announced a nationwide effort to combat Medicaid fraud, requiring states to submit provider revalidation plans. Separately, health insurers declined to participate in a Medicare pilot program for discounted weight loss drugs, prompting…
citizen.co.zaGLP-1 Weight Loss Drugs Drive Potential $13 Billion Boost in Apparel Retail Spending
Millions of individuals using GLP-1 drugs for weight loss are increasing their purchases of new clothing from retailers. Equity research firm Bernstein estimates this trend could generate up to $13 billion in annual spending for the apparel sector. The development highlights a gr…
Eli Lilly Launches Oral GLP-1 Medication Orforglipron for Weight Loss in the United States
Eli Lilly and Company has introduced Foundayo, the brand name for orforglipron, an oral GLP-1 receptor agonist approved for weight management. The pill offers a non-injectable alternative to existing treatments in the growing obesity drug market. Availability begins in the US, ta…
sciencenews.orgGenetic Variants Linked to Weight Loss Outcomes and Side Effects from GLP-1 Drugs
A study published in Nature identifies variations in two genes associated with greater weight loss and increased side effects from GLP-1 receptor agonist drugs like Wegovy and Mounjaro. The research, based on data from 15,000 to nearly 28,000 23andMe users, shows modest genetic i…
Rise in Testing of Unregulated Peptides in UK Amid Weight-Loss and Wellness Demand
Laboratories in the UK and internationally are processing thousands of samples of unregulated peptides sent by consumers for quality verification. These substances, often marketed for weight loss, biohacking, and anti-aging, include experimental compounds like retatrutide, which…